Washout allometric reference method (WARM) for parametric analysis of [11C]PIB in human brains

Frontiers in Aging Neuroscience

Volumn 5, Issue NOV, 2013, Pages

  Rodell, Anders ^a   Aanerud, Joel ^a   Braendgaard, Hans ^a   Gjedde, Albert ^a,b  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Alzheimer's disease; A ; CBF; Flow normalization; Parametric imaging; PIB

Indexed keywords

AMYLOID BETA PROTEIN; PITTSBURGH COMPOUND B;

AGED; ALLOMETRY; ALZHEIMER DISEASE; AMYLOID PLAQUE; ANALYTIC METHOD; ARTICLE; BRAIN BLOOD FLOW; BRAIN CIRCULATION; BRAIN TISSUE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GRAY MATTER; HUMAN; HUMAN TISSUE; MALE; NOISE REDUCTION; PARAMETRIC TEST; SIGNAL NOISE RATIO; WASHOUT ALLOMETRIC REFERENCE METHOD;

EID: 84895804555     PISSN: None     EISSN: 16634365     Source Type: Journal    
DOI: 10.3389/fnagi.2013.00045     Document Type: Article

References (36)

1. Blomquist, G. (1984). On the construction of functional maps in position emission tomography. J. Cereb. Blood Flow Metab. 4, 629-632. doi: 10.1038/jcbfm.1984.89.
2. Borghammer, P., Aanerud, J., and Gjedde, A. (2009a). Data-driven intensity normalization of PET group comparison studies is superior to global mean normalization. Neuroimage 46, 981-988. doi: 10.1016/j.neuroimage.2009.03.021.
3. Borghammer, P., Cumming, P., Aanerud, J., Förster, S., and Gjedde, A. (2009b). Subcortical elevation of metabolism in Parkinson's disease-a critical reappraisal in the context of global mean normalization. Neuroimage 47, 1514-1521. doi: 10.1016/j.neuroimage.2009.05.040.
4. Cohen, A. D., Rabinovici, G. D., Mathis, C. A., Jagust, W. J., Klunk, W. E., and Ikonomovic, M. D. (2012). Using Pittsburgh compound B for in vivo PET imaging of fibrillar amyloid-beta. Adv. Pharmacol. 64, 27-81. doi: 10.1016/B978-0-12-394816-8.00002-7.
5. Collins, D. L., Neelin, P., Peters, T. M., and Evans, A. C. (1994). Automatic 3D inter-subject registration of MR volumetric data in standardized talairach space. J. Comput. Assist. Tomogr. 18, 192-205. doi: 10.1097/00004728-199403000-00005.
6. Crone, C. (1963). The permeability of capillaries in various organs as measured by 'indicator diffusion' method. Acta Physiol. Scand. 58, 292-305. doi: 10.1111/j.1748-1716.1963.tb02652.x.
7. Ducharme, S., Guiot, M. C., Nikelski, J., and Chertkow, H. (2013). Does a positive Pittsburgh compound B scan in a patient with dementia equal Alzheimer disease? JAMA Neurol. 70, 912-914. doi: 10.1001/jamaneurol.2013.420.
8. Fodero-Tavoletti, M. T., Rowe, C. C., McLean, C. A., Leone, L., Li, Q. X., Masters, C. L., et al. (2009). Characterization of PiB binding to white matter in Alzheimer disease and other dementias. J. Nucl. Med. 50, 198-204. Epub 2009 Jan 21. doi: 10.2967/jnumed.108.057984.
9. Gjedde, A., Aanerud, J., Braendgaard, H., and Rodell, A. (2013). Blood-brain transfer of Pittsburgh compound B in humans. Front. Aging Neurosci. 5:70. doi: 10.3389/fnagi.2013.00070.
10. Grabner, G., Janke, A. L., Budge, M. M., Smith, D., Pruessner, J., and Collins, D. L. (2006). Symetric atlasing and model based segmentation: an application to the Hippocampus in older adults. Med. Image Comput. Comput. Assist. Interv. 9(Pt 2), 58-66. doi: 10.1007/11866763_8.
11. Hirvonen, J., Kajander, J., Allonen, T., Oikonen, V., Någren, K., and Hietala, J. (2007). Measurement of serotonin 5-HT1A receptor binding using positron emission tomography and [carbonyl-(11)C]WAY-100635-considerations on the validity of cerebellum as a reference region. J. Cereb. Blood Flow Metab. 27, 185-195. doi: 10.1038/sj.jcbfm.9600326.
12. Ikonomovic, M. D., Abrahamson, E. E., Price, J. C., Hamilton, R. L., Mathis, C. A., Paljug, W. R., et al. (2012). Early AD pathology in a [C-11]PiB-negative case: a PiB-amyloid imaging, biochemical, and immunohistochemical study. Acta Neuropathol. 123, 433-447. doi: 10.1007/s00401-012-0943-2.
13. Johannsen, P., Jakobsen, J., and Gjedde, A. (2000). Statistical maps of cerebral blood flow deficits in Alzheimer's disease. Eur. J. Neurol. 7, 385-392. doi: 10.1046/j.1468-1331.2000.00088.x.
14. Joshi, A. D., Pontecorvo, M. J., Clark, C. M., Carpenter, A. P., Jennings, D. L., Sadowsky, C. H., et al. (2012). Performance characteristics of amyloid PET with florbetapir F 18 in patients with Alzheimer's disease and cognitively normal subjects. J. Nucl. Med. 53, 378-384. doi: 10.2967/jnumed.111.090340.
15. Kanno, I., and Uemura, K. (1975). Some experimental errors in calculating regional cerebral blood flow from the intracarotid 133Xe clearance curve. A quantitative evaluation employing a digital model. Stroke 6, 370-375. doi: 10.1161/01.STR.6.4.370.
16. Kepe, V., Moghbel, M. C., Långström, B., Zaidi, H., Vinters, H. V., Huang, S. C., et al. (2013). Amyloid-β positron emission tomography imaging probes: a critical review. J. Alzheimers Dis. 36, 613-631. doi: 10.3233/JAD-130485.
17. Klunk, W. E., Engler, H., Nordberg, A., Wang, Y., Blomqvist, G., Holt, D. P., et al. (2004). Imaging brain amyloid in Alzheimer's disease with Pittsburgh compound-B. Ann. Neurol. 55, 306-319. doi: 10.1002/ana.20009.
18. Klunk, W. E., Price, J. C., Mathis, C. A., Tsopelas, N. D., Lopresti, B. J., Ziolko, S. K., et al. (2007). Amyloid deposition begins in the striatum of presenilin-1 mutation carriers from two unrelated pedigrees. J. Neurosci. 27, 6174-6184. doi: 10.1523/JNEUROSCI.0730-07.2007.
19. Knight, W. D., Okello, A. A., Ryan, N. S., Turkheimer, F. E., Rodríguez Martinez de Llano, S., Edison, P., et al. (2011). Carbon-11-Pittsburgh compound B positron emission tomography imaging of amyloid deposition in presenilin 1 mutation carriers. Brain 134(Pt 1), 293-300. Epub 2010 Nov 16. doi: 10.1093/brain/awq310.
20. Lammertsma, A. A., and Hume, S. P. (1996). Simplified reference tissue model for PET receptor studies. Neuroimage 4(3 Pt 1), 153-158. doi: 10.1006/nimg.1996.0066.
21. Landau, S. M., Breault, C., Joshi, A. D., Pontecorvo, M., Mathis, C. A., Jagust, W. J., et al. (2013). Alzheimer's disease neuroimaging initiative. Amyloid imaging with Pittsburgh compound B and florbetapir: comparing radiotracers and quantification methods. J. Nucl. Med. 54, 70-77. doi: 10.2967/jnumed.112.109009.
22. Lawson, G., and Hanson, R. J. (1974). Solving Least Squares Problems. New Jersey: Prentice Hall Inc.
23. Lehmann, M., Ghosh, P. M., Madison, C., Laforce, R. Jr., Corbetta-Rastelli, C., Weiner, M. W., et al. (2013). Diverging patterns of amyloid deposition and hypometabolism in clinical variants of probable Alzheimer's disease. Brain 136(Pt 3), 844-858. doi: 10.1093/brain/aws327.
24. Lolk, A., Nielsen, H., Andersen, K., Andersen, J., and Kragh-Srensen, P. (2000). CAMCOG as a screening instrument for dementia: the Odense study. Cambridge cognitive examination. Acta Psychiatr. Scand. 102, 331-335. doi: 10.1034/j.1600-0447.2000.102005331.x.
25. Møller, M., Rodell, A., and Gjedde, A. (2009). Parametric mapping of 5HT1A receptor sites in the human brain with the Hypotime method: theory and normal values. J. Nucl. Med. 50, 1229-1236. doi: 10.2967/jnumed.108.053322.
26. Mayr, E. (1982). The Growth of Biological Thought. Cambridge, MA: Harvard University press.
27. Mazziotta, J. A., Toga, A. W., Evans, A. C., Fox, P. T., Lancaster, J., Zilles, K., et al. (2001). A probabilistic atlas and reference system for the human brain: international consortium for brain mapping (ICBM). Philos. Trans. R. Soc. Lond. B Biol. Sci. 356, 1293-1322. doi: 10.1098/rstb.2001.0915.
28. Nilsson, P., Loganathan, K., Sekiguchi, M., Matsuba, Y., Hui, K., Tsubuki, S., et al. (2013). Aβ Secretion and plaque formation depend on autophagy. Cell Rep. 5, 61-69. doi: 10.1016/j.celrep.2013.08.042.
29. 15O]water clearance in humansdetermined by PET: I. Theory and normal values. J. Cereb. Blood Flow Metab. 16, 765-780. doi: 10.1097/00004647-199609000-00002.
30. Renkin, E. M. (1964). Transport of large molecules across capillary walls. Physiologist 60, 13-28.
31. Rodell, A. B., Aanerud, J., Braendgaard, H., and Gjedde, A. (2012). Low residual CBF variability in Alzheimer's disease after correction for CO(2) effect. Front. Neuroenergetics. 4:8. doi: 10.3389/fnene.2012.00008.
32. Rosen, R. F., Ciliax, B. J., Wingo, T. S., Gearing, M., Dooyema, J., Lah, J. J., et al. (2010). Deficient high-affinity binding of Pittsburgh compound B in a case of Alzheimer's disease. Acta Neuropathol. 119, 221-233. doi: 10.1007/s00401-009-0583-3.
33. Svedberg, M. M., Hall, H., Hellström-Lindahl, E., Estrada, S., Guan, Z., Nordberg, A., et al. (2009). [(11)C]PIB-amyloid binding and levels of Abeta40 and Abeta42 in postmortem brain tissue from Alzheimer patients. Neurochem. Int. 54, 347-357. doi: 10.1016/j.neuint.2008.12.016.
34. Varrone, A., Sjöholm, N., Eriksson, L., Gulyás, B., Halldin, C., and Farde, L. (2009). Advancement in PET quantification using 3D-OP-OSEM point spread function reconstruction with the HRRT. Eur. J. Nucl. Med. Mol. Imag. 36, 1639-1650. doi: 10.1007/s00259-009-1156-3.
35. Villemagne, V. L., Klunk, W. E., Mathis, C. A., Rowe, C. C., Brooks, D. J., Hyman, B. T., et al. (2012). Aβ imaging: feasible, pertinent, and vital to progress in Alzheimer's disease. Eur. J. Nucl. Med. Mol. Imag. 39, 209-219. doi: 10.1007/s00259-011-2045-0.
36. Zierler, K. L. (1965). Equations for measuring blood flow by external monitoring of radioisotope. Circ. Res. 16, 309-321. doi: 10.1161/01.RES.16.4.309.